A real-time PCR-based quantitative assay for 3-methylcytosine demethylase activity of ALKBH3

Biochemistry and Biophysics Reports

Volumn 5, Issue , 2016, Pages 476-481

  Ueda, Yuko ^a   Kitae, Kaori ^a   Ooshio, Ikumi ^a   Fusamae, Yasuyuki ^a   Kawaguchi, Megumi ^a   Jingushi, Kentaro ^a   Harada, Kazuo ^a   Hirata, Kazumasa ^a   Tsujikawa, Kazutake ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

3 methylcytosine; AlkB; ALKBH3; Demethylation; RT PCR

Indexed keywords

ALKB HOMOLOG 3 PROTEIN; CYTOSINE DERIVATIVE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BOMBYX MORI; CONTROLLED STUDY; DEMETHYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOLECULARLY TARGETED THERAPY; NONHUMAN; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84958259958     PISSN: None     EISSN: 24055808     Source Type: Journal    
DOI: 10.1016/j.bbrep.2016.02.007     Document Type: Article

References (19)

1. Trewick S.C., Henshaw T.F., Hausinger R.P., Lindahl T., Sedgwick B. Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature 2002, 419:174-178.
2. Drablos F., Feyzi E., Aas P.A., Vaagbo C.B., Kavli B., Bratlie M.S., Pena-Diaz J., Otterlei M., Slupphaug G., Krokan H.E. Alkylation damage in DNA and RNA-repair mechanisms and medical significance. DNA Repair 2004, 3:1389-1407.
3. Tsujikawa K., Koike K., Kitae K., Shinkawa A., Arima H., Suzuki T., Tsuchiya M., Makino Y., Furukawa T., Konishi N., Yamamoto H. Expression and sub-cellular localization of human ABH family molecules. J. Cell. Mol. Med. 2007, 11:1105-1116.
4. Jia G., Fu Y., Zhao X., Dai Q., Zheng G., Yang Y., Yi C., Lindahl T., Pan T., Yang Y.G., He C. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 2011, 7:885-887.
5. Aas P.A., Otterlei M., Falnes P.O., Vagbo C.B., Skorpen F., Akbari M., Sundheim O., Bjoras M., Slupphaug G., Seeberg E., Krokan H.E. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 2003, 421:859-863.
6. Duncan T., Trewick S.C., Koivisto P., Bates P.A., Lindahl T., Sedgwick B. Reversal of DNA alkylation damage by two human dioxygenases. Proc. Natl. Acad. Sci. USA 2002, 99:16660-16665.
7. Konishi N., Nakamura M., Ishida E., Shimada K., Mitsui E., Yoshikawa R., Yamamoto H., Tsujikawa K. High expression of a new marker PCA-1 in human prostate carcinoma. Clin. Cancer Res. 2005, 11:5090-5097.
8. Yamato I., Sho M., Shimada K., Hotta K., Ueda Y., Yasuda S., Shigi N., Konishi N., Tsujikawa K., Nakajima Y. PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis. Cancer Res. 2012, 72:4829-4839.
9. Tasaki M., Shimada K., Kimura H., Tsujikawa K., Konishi N. ALKBH3, a human AlkB homologue, contributes to cell survival in Human non-small-cell lung cancer. Br. J. Cancer 2011, 104:700-706.
10. Hotta K., Sho M., Fujimoto K., Shimada K., Yamato I., Anai S., Harada H., Tsujikawa K., Konishi N., Shinohara N., Nakajima Y. Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma. Oncol. Rep. 2015, 34:648-654.
11. Shimada K., Nakamura M., Ishida E., Higuchi T., Yamamoto H., Tsujikawa K., Konishi N. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Sci. 2008, 99:39-45.
12. Koike K., Ueda Y., Hase H., Kitae K., Fusamae Y., Masai S., Inagaki T., Saigo Y., Hirasawa S., Nakajima K., Ohshio I., Makino Y., Konishi N., Yamamoto H., Tsujikawa K. Anti-tumor effect of AlkB homolog 3 knockdown in hormone- independent prostate cancer cells. Curr. Cancer Drug Targets 2012, 12:847-856.
13. Karkhanina A.A., Mecinovic J., Musheev M.U., Krylova S.M., Petrov A.P., Hewitson K.S., Flashman E., Schofield C.J., Krylov S.N. Direct analysis of enzyme-catalyzed DNA demethylation. Anal. Chem. 2009, 81:5871-5875.
14. Welford R.W., Schlemminger I., McNeill L.A., Hewitson K.S., Schofield C.J. The selectivity and inhibition of AlkB. J. Biol. Chem. 2003, 278:10157-10161.
15. Woon E.C., Demetriades M., Bagg E.A., Aik W., Krylova S.M., Ma J.H., Chan M., Walport L.J., Wegman D.W., Dack K.N., McDonough M.A., Krylov S.N., Schofield C.J. Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase. J. Med. Chem. 2012, 55:2173-2184.
16. Honjo E., Shoyama Y., Tamada T., Shigematsu H., Hatanaka T., Kanaji S., Arima K., Ito Y., Izuhara K., Kuroki R. Expression of the extracellular region of the human interleukin-4 receptor alpha chain and interleukin-13 receptor alpha1 chain by a silkworm-baculovirus system. Protein Expr. Purif. 2008, 60:25-30.
17. Liu B.Q., Wu Y.D., Li P.H., Wei J.X., Zhang T., Liu R.L. Prostate cancer antigen-1 as a potential novel marker for prostate cancer. Asian J. Androl. 2007, 9:821-826.
18. Dango S., Mosammaparast N., Sowa M.E., Xiong L.J., Wu F., Park K., Rubin M., Gygi S., Harper J.W., Shi Y. DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation. Mol. cell 2011, 44:373-384.
19. Nakao S., Mabuchi M., Shimizu T., Itoh Y., Takeuchi Y., Ueda M., Mizuno H., Shigi N., Ohshio I., Jinguji K., Ueda Y., Yamamoto M., Furukawa T., Aoki S., Tsujikawa K., Tanaka A. Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs. Bioorg. Med. Chem. Lett. 2014, 24:1071-1074.